These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34277987)

  • 1. Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control.
    Soto-Mota A; Norwitz NG; Evans R; Clarke K; Barber TM
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00264. PubMed ID: 34277987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults.
    Soto-Mota A; Vansant H; Evans RD; Clarke K
    Regul Toxicol Pharmacol; 2019 Dec; 109():104506. PubMed ID: 31655093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the Metabolism of Exogenous Ketones in Humans.
    Stubbs BJ; Cox PJ; Evans RD; Santer P; Miller JJ; Faull OK; Magor-Elliott S; Hiyama S; Stirling M; Clarke K
    Front Physiol; 2017; 8():848. PubMed ID: 29163194
    [No Abstract]   [Full Text] [Related]  

  • 4. Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis.
    Soto-Mota A; Norwitz NG; Evans RD; Clarke K
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00300. PubMed ID: 34787952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acute and 14-day exogenous ketone supplementation on glycemic control in adults with type 2 diabetes: two randomized controlled trials.
    Falkenhain K; Oliveira BF; Islam H; Neudorf H; Cen HH; Johnson JD; Madden K; Singer J; Walsh JJ; Little JP
    Am J Physiol Endocrinol Metab; 2024 Jan; 326(1):E61-E72. PubMed ID: 37991451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.
    Aroda VR; Bain SC; Cariou B; Piletič M; Rose L; Axelsen M; Rowe E; DeVries JH
    Lancet Diabetes Endocrinol; 2017 May; 5(5):355-366. PubMed ID: 28344112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.
    Putananickal N; Gross EC; Orsini AL; Schmidt S; Hafner P; Gocheva V; Nagy S; Henzi BC; Rubino D; Schädelin S; Sandor P; Fischer D
    Front Pharmacol; 2023; 14():1172483. PubMed ID: 37214431
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerability and Acceptability of an Exogenous Ketone Monoester and Ketone Monoester/Salt Formulation in Humans.
    Bolyard ML; Graziano CM; Fontaine KR; Sayer RD; Fisher G; Plaisance EP
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals.
    Myette-Côté É; Neudorf H; Rafiei H; Clarke K; Little JP
    J Physiol; 2018 Apr; 596(8):1385-1395. PubMed ID: 29446830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional ketosis delays the onset of isoflurane induced anesthesia.
    Ari C; Kovács Z; Murdun C; Koutnik AP; Goldhagen CR; Rogers C; Diamond D; D'Agostino DP
    BMC Anesthesiol; 2018 Jul; 18(1):85. PubMed ID: 30021521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
    Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague-Dawley rats.
    Kesl SL; Poff AM; Ward NP; Fiorelli TN; Ari C; Van Putten AJ; Sherwood JW; Arnold P; D'Agostino DP
    Nutr Metab (Lond); 2016; 13():9. PubMed ID: 26855664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short term optimization of glycaemic control using insulin improves sympatho-vagal tone activities in patients with type 2 diabetes.
    Mba CM; Nganou-Gnindjio CN; Azabji-Kenfack M; Mfeukeu-Kuate L; Dehayem MY; Mbanya JC; Sobngwi E
    Diabetes Res Clin Pract; 2019 Nov; 157():107875. PubMed ID: 31586660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice.
    Suissa L; Kotchetkov P; Guigonis JM; Doche E; Osman O; Pourcher T; Lindenthal S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
    Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
    Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial.
    Selvaraj S; Margulies KB; Dugyala S; Schubert E; Tierney A; Arany Z; Pryma DA; Shah SH; Rame JE; Kelly DP; Bravo PE
    J Nucl Med; 2022 May; 63(5):770-776. PubMed ID: 34675108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional ketosis is well-tolerated, even in type 1 diabetes: the ZeroFive100 Project; a proof-of-concept study.
    Lake I
    Curr Opin Endocrinol Diabetes Obes; 2021 Oct; 28(5):453-462. PubMed ID: 34334612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.